Featured Research

from universities, journals, and other organizations

More Patients Across The World Lowering 'Bad' Cholesterol

June 24, 2009
American Heart Association
More people in the past decade have lowered their level of "bad" LDL cholesterol to acceptable ranges. In the United States, the overall compliance rate of LDL at target levels has nearly doubled since 1996. About one third of high-risk patients still need to attain LDL goals through adequate treatment.

The percentage of patients lowering their elevated “bad” cholesterol to within target levels nearly doubled in the last decade, according to a multi-national survey reported in Circulation: Journal of the American Heart Association.

In the Lipid Treatment Assessment Project (L-TAP) 2 — a survey of nearly 10,000 patients (average age 62) from nine countries undergoing cholesterol-lowering and management efforts — researchers found that:

  • The number of patients successfully reaching their respective low-density lipoprotein (LDL) levels rose from 38 percent to 73 percent over the last 10 years.
  • Among high-risk patients, 67 percent reached established goal levels.
  • Only 30 percent of very high risk patients — those with existing coronary artery disease and two or more other risk factors such as obesity, diabetes and smoking — successfully reached their LDL target of 70 milligrams per deciliter (mg/dL) or less.

LDL is known as “bad” cholesterol because it’s associated with increased cardiovascular risk.

“Although there is room for improvement, particularly in very high-risk patients, these results indicate that lipid-lowering therapy is being applied much more successfully than it was a decade ago,” said David D. Waters, M.D., lead author of the study and Emeritus Professor, University of California, San Francisco.

Researchers examined compliance with LDL goals outlined in the National Cholesterol Education Program Adult Treatment Panel (NCEP ATP) III, the 2003 Joint European Societies, or the 2003 Canadian Working Group. Countries in the study were the United States, Canada, Mexico, the Netherlands, Spain, France, Brazil, South Korea and Taiwan.

LDL cholesterol goals in the United States depend on how many risk factors are present, according to NCEP ATP III guidelines:

  • For people without coronary heart disease, diabetes or cardiovascular risk factors, the goal is less than 160 mg/dL.
  • For people without coronary heart disease or diabetes, but who have two or more cardiovascular risk factors, the goal is less than 130 mg/dL.
  • For patients with coronary heart disease or diabetes, the goal is less than 100 mg/dL. But when risk is very high, a goal of less than 70 mg/dL is a therapeutic option.

Researchers found that 75 percent of the patients surveyed were taking a statin drug (atorvastatin, simvastatin, rosuvastatin or pravastatin). The median duration of therapy was two years. Others were treated with fibrates, ezetimbe or lifestyle changes such as diet and exercise alone.

In 1996–97, only 38 percent of patients in the United States were achieving recommended cholesterol goals and just 18 percent of those with coronary heart disease were at goal. The new study found the success rate was 86 percent in low-risk patients, 74 percent in those at moderate risk and 67 percent in high-risk patients.

In the survey, average LDL levels were 119 mg/dL in the low-risk group, 109 mg/dL among those at moderate risk and 91 mg/dL in high-risk groups.

The researchers also reviewed high-density lipoprotein (HDL), or “good” cholesterol levels. In the entire group, HDL cholesterol was optimal — about 60 mg/dL in 26 percent of patients and below 40 mg/dL in 19 percent. The average HDL cholesterol levels were 62 mg/dL for low-risk patients, 49 mg/dL for moderate-risk and 50 mg/dL for high-risk patients.

The proportion of patients achieving LDL goals according to relevant national guidelines ranged from 47 percent in Spain to 84 percent in South Korea. Researchers couldn’t explain the variation among countries.

In an accompanying editorial, Antonio M. Gotto, Jr., M.D., D.Phil, notes that these results indicate there is still a considerable gap in the treatment of patients at highest risk for cardiovascular events.

“Rates of obesity and diabetes have worsened over the past decade, and cardioprotective drugs can only do so much to remedy the metabolic complications that often result from poor lifestyle choices,” writes Gotto, professor of medicine at Weill Cornell Medical College in New York. “Effectively addressing global cardiovascular risk requires an increased focus on lifestyle, as well as lipids.”

Co-authors of the study are Carlos Brotons, M.D.; Cheng-Wen Chiang, M.D.; Jean Ferriθres, M.D.; JoAnne Foody, M.D.; J. Wouter Jukema, M.D.; Raul D. Santos, M.D.; Juan Verdejo, M.D.; Michael Messig, Ph.D; Ruth McPherson, M.D.; Ki-Bae Seung, M.D.; and Lisa Tarasenko, Pharm.D.; on behalf of the L-TAP 2 Investigators. Individual author disclosures can be found on the manuscript.

Pfizer, Inc. funded the study.

Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.

Cite This Page:

American Heart Association. "More Patients Across The World Lowering 'Bad' Cholesterol." ScienceDaily. ScienceDaily, 24 June 2009. <www.sciencedaily.com/releases/2009/06/090622163029.htm>.
American Heart Association. (2009, June 24). More Patients Across The World Lowering 'Bad' Cholesterol. ScienceDaily. Retrieved October 23, 2014 from www.sciencedaily.com/releases/2009/06/090622163029.htm
American Heart Association. "More Patients Across The World Lowering 'Bad' Cholesterol." ScienceDaily. www.sciencedaily.com/releases/2009/06/090622163029.htm (accessed October 23, 2014).

Share This

More Health & Medicine News

Thursday, October 23, 2014

Featured Research

from universities, journals, and other organizations

Featured Videos

from AP, Reuters, AFP, and other news services

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) — Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) — Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
US to Track Everyone Coming from Ebola Nations

US to Track Everyone Coming from Ebola Nations

AP (Oct. 22, 2014) — Stepping up their vigilance against Ebola, federal authorities said Wednesday that everyone traveling into the US from Ebola-stricken nations will be monitored for symptoms for 21 days. (Oct. 22) Video provided by AP
Powered by NewsLook.com
Doctors Help Paralysed Man Walk Again, Patient in Disbelief

Doctors Help Paralysed Man Walk Again, Patient in Disbelief

AFP (Oct. 22, 2014) — Polish doctors describe how they helped a paralysed man walk again, with the patient in disbelief at the return of sensation to his legs. Duration: 1:04 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.


Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News


Free Subscriptions

Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile

Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins